Mark P Farrell

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Chronic Myeloid Leukemia

Top Venues

Angewandte Chemie (International ed. in English)

ACS chemical biology

ACS pharmacology & translational science

Chemical record (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Aleksandra Baranczak, Simone V Bigi-Botterill, Chiara Borsari, Amanda W Dombrowski, Michelle A Estrada, Mark P Farrell, Andrew P Riley, John G Woodland
Announcing the Early Career Board of ACS Medicinal Chemistry Letters . ACS medicinal chemistry letters 15 (9) (2024)
Kyle D Apley, Amber S Griffith, Grant M Downes, Patrick Ross, Mark P Farrell, Peggy Kendall, Cory J Berkland
CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell Activation. Bioconjugate chemistry (2023)
Stephanie N Johnson, Spencer D Brucks, Kyle D Apley, Mark P Farrell, Cory J Berkland
Multivalent Scaffolds to Promote B cell Tolerance. Molecular pharmaceutics (2023)
Aric Huang, Suresh E Kurhade, Patrick Ross, Kyle D Apley, Jonathan Daniel Griffin, Cory J Berkland, Mark P Farrell
Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling. ACS pharmacology & translational science 5 (11) (2022)
Kathia Antillon, Patrick A Ross, Mark P Farrell
Directing CAR NK Cells via the Metabolic Incorporation of CAR Ligands into Malignant Cell Glycans. ACS chemical biology 17 (6) (2022)
Suresh E Kurhade, Patrick Ross, Fei Philip Gao, Mark P Farrell
Lectin Drug Conjugates Targeting High Mannose N-Glycans. Chembiochem : a European journal of chemical biology 23 (19) (2022)
Suresh E Kurhade, Jack D Weiner, Fei Philip Gao, Mark P Farrell
Functionalized High Mannose-Specific Lectins for the Discovery of Type I Mannosidase Inhibitors. Angewandte Chemie (International ed. in English) 60 (22) (2021)
Patrick Ross, Mark P Farrell
The Road to Structurally Defined β-Glucans. Chemical record (New York, N.Y.) 21 (11) (2021)